[amazon_link asins=’B0179785OO,B00GB85JR4,B004U3Y8OM,B0032BH76O,B00JGCBGZQ,B004XLRTUQ,B0037LOLKY,B06XP3B13K,B004GJYTF8′ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’31326bfb-6526-11e7-a257-efee82b62f2a’]
A meta-analysis of 18 randomized controlled trials has found that supplemental vitamin D significantly reduces mortality from all causes.
The analysis emphasizes the medical, ethical, and legal implications of promptly diagnosing and adequately treating vitamin D deficiency.
Not only are such deficiencies common, but vitamin D deficiency is implicated in most of the diseases of civilization. Vitamin D’s final metabolic product targets more than 200 human genes in a wide variety of tissues. One of the most important genes vitamin D up-regulates is for cathelicidin, a naturally occurring broad-spectrum antibiotic.
Since vitamin D deficiency is both endemic and is associated with numerous diseases, it is one of the most important medical problems in modern society. Treatment of vitamin D deficiency in otherwise healthy patients must be individualized due to the numerous factors affecting vitamin D levels. Steps should be taken to keep patients with chronic diseases associated with vitamin D deficiency, especially internal cancers, in the higher normal range of vitamin D blood levels.